WallStSmart

Enhabit Inc. (EHAB)vsTenet Healthcare Corporation (THC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tenet Healthcare Corporation generates 1924% more annual revenue ($21.45B vs $1.06B). THC leads profitability with a 7.9% profit margin vs -0.4%. THC earns a higher WallStSmart Score of 66/100 (B-).

EHAB

Hold

48

out of 100

Grade: D+

Growth: 5.3Profit: 4.0Value: 6.7Quality: 6.0
Piotroski: 5/9Altman Z: 1.71

THC

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 7.3Quality: 6.3
Piotroski: 6/9Altman Z: 1.69
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EHABUndervalued (+77.5%)

Margin of Safety

+77.5%

Fair Value

$50.06

Current Price

$13.78

$36.28 discount

UndervaluedFair: $50.06Overvalued
THCUndervalued (+78.8%)

Margin of Safety

+78.8%

Fair Value

$1068.55

Current Price

$191.68

$876.87 discount

UndervaluedFair: $1068.55Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EHAB2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

EPS GrowthGrowth
8667.0%10/10

Earnings expanding 8667.0% YoY

THC4 strengths · Avg: 9.5/10
P/E RatioValuation
9.9x10/10

Attractively priced relative to earnings

Return on EquityProfitability
30.3%10/10

Every $100 of equity generates 30 in profit

EPS GrowthGrowth
87.6%10/10

Earnings expanding 87.6% YoY

Free Cash FlowQuality
$1.46B8/10

Generating 1.5B in free cash flow

Areas to Watch

EHAB4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Market CapQuality
$706.40M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-0.5%2/10

ROE of -0.5% — below average capital efficiency

THC4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.8%4/10

2.8% revenue growth

Altman Z-ScoreHealth
1.694/10

Distress zone — elevated risk

Profit MarginProfitability
7.9%3/10

7.9% margin — thin

PEG RatioValuation
4.702/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : EHAB

The strongest argument for EHAB centers on Price/Book, EPS Growth.

Bull Case : THC

The strongest argument for THC centers on P/E Ratio, Return on Equity, EPS Growth.

Bear Case : EHAB

The primary concerns for EHAB are Revenue Growth, Altman Z-Score, Market Cap.

Bear Case : THC

The primary concerns for THC are Revenue Growth, Altman Z-Score, Profit Margin.

Key Dynamics to Monitor

EHAB profiles as a turnaround stock while THC is a value play — different risk/reward profiles.

THC carries more volatility with a beta of 1.30 — expect wider price swings.

EHAB is growing revenue faster at 4.7% — sustainability is the question.

THC generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

THC scores higher overall (66/100 vs 48/100). EHAB offers better value entry with a 77.5% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Enhabit Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Enhabit, Inc. provides home health and hospice services in the United States.

Visit Website →

Tenet Healthcare Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.

Want to dig deeper into these stocks?